Authors: Askling, J Dickman, PW Karlen, P Brostrom, O Lapidus, A Lofberg, R Ekbom, A

Citation: J. Askling et al., Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study, LANCET, 357(9252), 2001, pp. 262-266

Authors: Askling, J Dickman, PW Karlen, P Brostrom, O Lapidus, A Lofberg, R Ekbom, A

Citation: J. Askling et al., Family history as a risk factor for colorectal cancer in inflammatory bowel disease, GASTROENTY, 120(6), 2001, pp. 1356-1362

Authors: Jarnerot, G Strom, M Danielsson, A Kilander, A Loof, L Hultcrantz, R Lofberg, R Floren, CH Nilsson, A Brostrom, O

Citation: G. Jarnerot et al., Allopurinol in addition to 5-aminosalicyclic acid based drugs for the maintenance treatment of ulcerative colitis, ALIM PHARM, 14(9), 2000, pp. 1159-1162

Authors: Karlen, P Lofberg, R Brostrom, O Leijonmarck, CE Hellers, G Persson, PG

Citation: P. Karlen et al., Increased risk of cancer in ulcerative colitis: A population-based cohort study, AM J GASTRO, 94(4), 1999, pp. 1047-1052

Authors: Karlen, P Young, E Brostrom, O Lofberg, R Tribukait, B Ost, A Bodian, C Itzkowitz, S

Citation: P. Karlen et al., Sialyl-tn antigen as a marker of colon cancer risk in ulcerative colitis: Relation to dysplasia and DNA aneuploidy, GASTROENTY, 115(6), 1998, pp. 1395-1404